Mark Bolstridge

6.3k total citations · 4 hit papers
17 papers, 3.5k citations indexed

About

Mark Bolstridge is a scholar working on Clinical Psychology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mark Bolstridge has authored 17 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Clinical Psychology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Cognitive Neuroscience. Recurrent topics in Mark Bolstridge's work include Psychedelics and Drug Studies (14 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Biochemical Analysis and Sensing Techniques (3 papers). Mark Bolstridge is often cited by papers focused on Psychedelics and Drug Studies (14 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Biochemical Analysis and Sensing Techniques (3 papers). Mark Bolstridge collaborates with scholars based in United Kingdom, United States and Germany. Mark Bolstridge's co-authors include Robin Carhart‐Harris, Mendel Kaelen, Amanda Feilding, David Erritzøe, Michael Bloomfield, David Nutt, David Nutt, James A. Rickard, James Rucker and Camilla Day and has published in prestigious journals such as Journal of Neuroscience, Current Biology and Scientific Reports.

In The Last Decade

Mark Bolstridge

16 papers receiving 3.4k citations

Hit Papers

Psilocybin with psychological support for treatment-resis... 2016 2026 2019 2022 2016 2017 2017 2016 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
    2016 1.0k citations Robin Carhart‐Harris, Mark Bolstridge et al. The Lancet Psychiatry profile →
  2. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
    2017 646 citations Robin Carhart‐Harris, Mark Bolstridge et al. Psychopharmacology profile →
  3. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
    2017 383 citations Robin Carhart‐Harris, Leor Roseman et al. Scientific Reports profile →
  4. Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution
    2016 315 citations Enzo Tagliazucchi, Leor Roseman et al. Current Biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bolstridge United Kingdom 14 3.2k 1.8k 1.8k 539 324 17 3.5k
Robin Carhart‐Harris United Kingdom 25 3.2k 1.0× 1.5k 0.9× 1.6k 0.9× 544 1.0× 263 0.8× 65 3.9k
Adam L. Halberstadt United States 37 3.4k 1.1× 2.6k 1.5× 1.8k 1.1× 595 1.1× 395 1.2× 90 4.6k
Michael Kometer Switzerland 22 2.4k 0.8× 1.5k 0.9× 1.2k 0.7× 491 0.9× 265 0.8× 37 3.1k
Mendel Kaelen United Kingdom 26 4.8k 1.5× 2.4k 1.4× 2.7k 1.5× 822 1.5× 477 1.5× 37 5.3k
Torsten Passie Germany 24 2.1k 0.7× 1.1k 0.6× 1.1k 0.6× 344 0.6× 470 1.5× 50 2.7k
Kim P. C. Kuypers Netherlands 39 2.9k 0.9× 1.7k 0.9× 1.3k 0.7× 439 0.8× 1.1k 3.3× 127 4.3k
Rick J. Strassman United States 29 2.8k 0.9× 1.5k 0.9× 1.2k 0.7× 690 1.3× 881 2.7× 52 3.8k
Patrick C. Dolder Switzerland 27 2.0k 0.6× 1.3k 0.7× 1.1k 0.6× 415 0.8× 189 0.6× 43 2.5k
Christopher Timmermann United Kingdom 24 2.1k 0.7× 943 0.5× 1.1k 0.6× 357 0.7× 172 0.5× 60 2.5k
Mary P Cosimano United States 5 3.3k 1.0× 1.5k 0.9× 2.1k 1.2× 444 0.8× 351 1.1× 6 3.4k

Countries citing papers authored by Mark Bolstridge

Since Specialization
Citations

This map shows the geographic impact of Mark Bolstridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bolstridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bolstridge more than expected).

Fields of papers citing papers by Mark Bolstridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bolstridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bolstridge. The network helps show where Mark Bolstridge may publish in the future.

Co-authorship network of co-authors of Mark Bolstridge

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bolstridge. A scholar is included among the top collaborators of Mark Bolstridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bolstridge. Mark Bolstridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Borissova, Anna, B. Ferguson, Matthew B. Wall, et al.. (2020). Acute effects of MDMA on trust, cooperative behaviour and empathy: A double-blind, placebo-controlled experiment. Journal of Psychopharmacology. 35(5). 547–555. 22 indexed citations
2.
Mick, Inge, John McGonigle, Mark Bolstridge, et al.. (2017). Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study. Biological Psychiatry. 81(11). 941–948. 27 indexed citations
3.
Porras‐Segovia, Alejandro, Amir Krivoy, Mark Horowitz, et al.. (2017). Rapid-onset clozapine-induced loss of glycaemic control: Case report. BJPsych Open. 3(3). 138–140. 8 indexed citations
4.
Carhart‐Harris, Robin, Mark Bolstridge, Camilla Day, et al.. (2017). Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology. 235(2). 399–408. 646 indexed citations breakdown →
5.
Joy, George, Eromona Whiskey, Mark Bolstridge, et al.. (2017). Hearts and Minds. Journal of Clinical Psychopharmacology. 37(6). 708–712. 5 indexed citations
6.
Carhart‐Harris, Robin, Leor Roseman, Mark Bolstridge, et al.. (2017). Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Scientific Reports. 7(1). 13187–13187. 383 indexed citations breakdown →
7.
Kaelen, Mendel, Leor Roseman, Joshua Kahan, et al.. (2016). LSD modulates music-induced imagery via changes in parahippocampal connectivity. European Neuropsychopharmacology. 26(7). 1099–1109. 89 indexed citations
8.
Tagliazucchi, Enzo, Leor Roseman, Mendel Kaelen, et al.. (2016). Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution. Current Biology. 26(8). 1043–1050. 315 indexed citations breakdown →
9.
Terhune, Devin B., David Luke, Mendel Kaelen, et al.. (2016). A placebo-controlled investigation of synaesthesia-like experiences under LSD. Neuropsychologia. 88. 28–34. 34 indexed citations
10.
Carhart‐Harris, Robin, Mark Bolstridge, James Rucker, et al.. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry. 3(7). 619–627. 1018 indexed citations breakdown →
11.
Family, Neiloufar, David Vinson, Gabriella Vigliocco, et al.. (2016). Semantic activation in LSD: evidence from picture naming. Language Cognition and Neuroscience. 31(10). 1320–1327. 29 indexed citations
12.
Carhart‐Harris, Robin, Mendel Kaelen, Mark Bolstridge, et al.. (2016). The paradoxical psychological effects of lysergic acid diethylamide (LSD). Psychological Medicine. 46(7). 1379–1390. 229 indexed citations
13.
Kaelen, Mendel, Frederick S. Barrett, Leor Roseman, et al.. (2015). LSD enhances the emotional response to music. Psychopharmacology. 232(19). 3607–3614. 111 indexed citations
14.
Carhart‐Harris, Robin, Mendel Kaelen, Matthew G. Whalley, et al.. (2014). LSD enhances suggestibility in healthy volunteers. Psychopharmacology. 232(4). 785–794. 210 indexed citations
15.
Carhart‐Harris, Robin, Matthew B. Wall, David Erritzøe, et al.. (2013). The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories. The International Journal of Neuropsychopharmacology. 17(4). 527–540. 78 indexed citations
16.
17.
Muthukumaraswamy, Suresh, Robin Carhart‐Harris, Rosalyn Moran, et al.. (2013). Broadband Cortical Desynchronization Underlies the Human Psychedelic State. Journal of Neuroscience. 33(38). 15171–15183. 322 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robin Carhart‐Harris Breakdown of academic impact, for papers by Adam L. Halberstadt Breakdown of academic impact, for papers by Michael Kometer Breakdown of academic impact, for papers by Mendel Kaelen Breakdown of academic impact, for papers by Torsten Passie Breakdown of academic impact, for papers by Kim P. C. Kuypers Breakdown of academic impact, for papers by Rick J. Strassman Breakdown of academic impact, for papers by Patrick C. Dolder Breakdown of academic impact, for papers by Christopher Timmermann Breakdown of academic impact, for papers by Mary P Cosimano
Rankless by CCL
2026